Li, D., T. Shimamura, H. B. Ji, L. Chen, H. J. Haringsma, K. McNamara, M.-C. Liang, S. A. Perera, S. Zaghlul, C. L. Borgman, S. Kubo, M. Takahashi, Y. P. Sun, L. R. Chirieac, R. F. Padera, N. I. Lindeman, P. A. Janni, R. K. Thomas, M. L. Meyerson, M. J. Eck, J. A. Engelman, G. I. Shapiro and K.-K. Wong: Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapy. In: Cancer Cell 12, 1, 81-93 (2007).
Ji, H., Z. Wang, S. A. Perera, D. Li, M.-C. Liang, S. Zaghlul, K. McNamara, L. Chen, M. Albert, Y. Sun, R. Al-Hashem, L. R. Chirieac, R. Padera, R. T. Bronson, R. K. Thomas, L. A. Garraway, P. A. Jänne, B. E. Johnson, L. Chin and K.-K. Wong: Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models. In: Cancer Research 67, 10, 4933-4939 (2007).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.